Article
COPI vesicle formation and N-myristoylation are targetable vulnerabilities of senescent cells
27 Nov 2023
Abstract excerpt
Drugs that selectively kill senescent cells (senolytics) improve the outcomes of cancer, fibrosis and age-related diseases. Despite their potential, our knowledge of the molecular pathways that affect the survival of senescent cells is limited. To discover senolytic targets, we performed RNAi screens and identified coatomer complex I (COPI) vesicle formation as a liability of senescent cells. Genetic or...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
